{
    "name": "adapalene/benzoyl peroxide",
    "comment": "Rx",
    "other_names": [
        "Epiduo",
        "Epiduo Forte"
    ],
    "classes": [
        "Acne Agents",
        "Topical Combos"
    ],
    "source": "https://reference.medscape.com/drug/epiduo-adapalene-benzoyl-peroxide-999747",
    "pregnancy": {
        "common": [
            "Available pharmacovigilance data in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes; animal reproduction studies have not been conducted with the combination gel"
        ],
        "specific": [
            {
                "type": "Adapalene gel, 0.3%",
                "description": [
                    "Available data from clinical trials with adapalene gel 0.3% use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes; in animal reproduction studies, oral administration of adapalene to pregnant rats and rabbits during organogenesis at dose exposures 41 and 81 times, respectively, the human exposure at maximum recommended human dose (MRHD) of 2 g resulted in fetal skeletal and visceral malformations"
                ]
            },
            {
                "type": "Benzoyl peroxide gel, 2.5%",
                "description": [
                    "The systemic exposure of benzoyl peroxide is unknown; based on published literature, benzoyl peroxide is rapidly metabolized to benzoic acid (an endogenous substance), which is eliminated in the urine; hence, maternal use is not expected to result in fetal exposure of the drug"
                ]
            },
            {
                "type": "Adapalene gel, 0.3%",
                "description": [
                    "Available data from clinical trials with adapalene gel 0.3% use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes; in animal reproduction studies, oral administration of adapalene to pregnant rats and rabbits during organogenesis at dose exposures 41 and 81 times, respectively, the human exposure at maximum recommended human dose (MRHD) of 2 g resulted in fetal skeletal and visceral malformations"
                ]
            },
            {
                "type": "Benzoyl peroxide gel, 2.5%",
                "description": [
                    "The systemic exposure of benzoyl peroxide is unknown; based on published literature, benzoyl peroxide is rapidly metabolized to benzoic acid (an endogenous substance), which is eliminated in the urine; hence, maternal use is not expected to result in fetal exposure of the drug"
                ]
            }
        ]
    },
    "lactation": {
        "common": []
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to adapalene, benzoyl peroxide or any of its components"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Avoid eyes, lips, and mucous membranes",
                "For external use only",
                "Do not apply to abrasions, cuts, eczematous or sunburned skin",
                "Do not wax treated area or apply topical products that may further irritate skin (eg, astringents, abrasive soaps, and cleansers, exfoliants)",
                "Hypersensitivity reactions, including anaphylaxis, angioedema, and urticaria, reported with use of benzoyl peroxide products; if a serious hypersensitivity reaction occurs, discontinue treatment immediately and initiate appropriate therapy",
                "Avoid exposure to sunlight, including sunlamps, during use; patients with high levels of sun exposure and those with inherent sensitivity to sun should exercise particular caution; use of broad-spectrum sunscreen products and protective apparel (eg, hat) are recommended when exposure cannot be avoided; weather extremes, such as wind or cold, may be irritating to patients under treatment ",
                "Patients with high levels of sun exposure and those with inherent sensitivity to sun should exercise particular caution",
                "Use of sunscreen products and protective apparel, (eg, hat) are recommended when exposure cannot be avoided",
                "Weather extremes, such as wind or cold, may be irritating to patients under treatment",
                "Erythema, scaling, dryness, and stinging/burning may be experienced with use; these are most likely to occur during first four weeks of treatment, are mostly mild to moderate in intensity, and usually lessen with continued use of medication",
                "Irritant and allergic contact dermatitis may occur; depending upon severity of these adverse reactions, patients should be instructed to use a moisturizer, reduce frequency of application, or discontinue use",
                "The product should not be applied to cuts, abrasions, eczematous or sunburned skin",
                "As with other retinoids, use of “waxing” as a depilatory method should be avoided on skin treated with this gel",
                "Avoid concomitant use of other potentially irritating topical products (medicated or abrasive soaps and cleansers, soaps and cosmetics that have strong skin-drying effect and products with high concentrations of alcohol, astringents, spices, or limes)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Stinging",
            "percent": "3-41"
        },
        {
            "name": "burning",
            "percent": "1-41"
        },
        {
            "name": "Dryness",
            "percent": "1-35"
        },
        {
            "name": "Scaling",
            "percent": "1-27"
        },
        {
            "name": "Erythema",
            "percent": "3"
        },
        {
            "name": "Contact dermatitis",
            "percent": "2"
        },
        {
            "name": "Application site burning",
            "percent": "1"
        },
        {
            "name": "Application site irritation",
            "percent": "1"
        },
        {
            "name": "Skin irritation",
            "percent": null
        },
        {
            "name": "Allergic contact dermatitis",
            "percent": null
        },
        {
            "name": "Blister",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Eczema",
            "percent": null
        },
        {
            "name": "Eyelid edema",
            "percent": null
        },
        {
            "name": "Local skin pain",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Swelling",
            "percent": null
        },
        {
            "name": "Skin discoloration",
            "percent": null
        },
        {
            "name": "Sunburn",
            "percent": null
        },
        {
            "name": "Throat tightness",
            "percent": null
        },
        {
            "name": "Hyperpigmentation and hypopigmentation",
            "percent": null
        }
    ]
}